Qulipta (atogepant) / Merck (MSD), AbbVie  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Qulipta (atogepant) / AbbVie
NCT04818515: Study To Assess Adverse Events and Drug to Drug Interaction of Oral Tablet Atogepant and Ubrogepant in Adult Participants With a History of Migraine

Completed
1b
26
US
Atogepant, Ubrogepant, UBRELVY
AbbVie
Migraine
06/21
06/21
NCT05892757: Study to Assess Adverse Events and Compare How Oral Ubrogepant and Oral Atogepant Moves Through the Body of Healthy Female Adult Volunteers

Completed
1
24
US
Atogepant, QULIPTA, Ubrogepant, UBRELVY
AbbVie
Healthy Volunteers
02/24
02/24

Download Options